ARHGEF3 and non-small cell lung carcinoma: The results indicated that knocking down ARHGEF3 did not or only slightly inhibited the proliferation of BEAS-2B cells, but the proliferation rate and colony-forming ability of NSCLC cells were significantly decreased (Fig. 1D–G).